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Background: Genes and signalling pathways involved in pluripotency have been studied extensively in mouse and
human pre-implantation embryos and embryonic stem (ES) cells. The unsuccessful attempts to generate ES cell lines
from other species including cattle suggests that other genes and pathways are involved in maintaining pluripotency in
these species. To investigate which genes are involved in bovine pluripotency, expression profiles were generated from
morula, blastocyst, trophectoderm and inner cell mass (ICM) samples using microarray analysis. As MAPK inhibition can
increase the NANOG/GATA6 ratio in the inner cell mass, additionally blastocysts were cultured in the presence of a MAPK
inhibitor and changes in gene expression in the inner cell mass were analysed.
Results: Between morula and blastocyst 3,774 genes were differentially expressed and the largest differences were
found in blastocyst up-regulated genes. Gene ontology (GO) analysis shows lipid metabolic process as the term most
enriched with genes expressed at higher levels in blastocysts. Genes with higher expression levels in morulae were
enriched in the RNA processing GO term. Of the 497 differentially expressed genes comparing ICM and TE, the expression
of NANOG, SOX2 and POU5F1was increased in the ICM confirming their evolutionary preserved role in pluripotency.
Several genes implicated to be involved in differentiation or fate determination were also expressed at higher levels
in the ICM. Genes expressed at higher levels in the ICM were enriched in the RNA splicing and regulation of gene
expression GO term. Although NANOG expression was elevated upon MAPK inhibition, SOX2 and POU5F1 expression
showed little increase. Expression of other genes in the MAPK pathway including DUSP4 and SPRY4, or influenced by
MAPK inhibition such as IFNT, was down-regulated.
Conclusion: The data obtained from the microarray studies provide further insight in gene expression during
bovine embryonic development. They show an expression profile in pluripotent cells that indicates a pluripotent,
epiblast-like state. The inability to culture ICM cells as stem cells in the presence of an inhibitor of MAPK activity
together with the reported data indicates that MAPK inhibition alone is not sufficient to maintain a pluripotent
character in bovine cells.
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In mammals, early life starts with the formation of a zygote
as a result of the fertilization of an oocyte. Sequential cleav-
age divisions lead to the formation of a morula stage embryo
wherein a fluid-filled cavity emerges called the blastocoel.
Two differentiated groups of cells can be distinguished in
the embryo that is now called a blastocyst. A group of cells
adjacent to the blastocoel, the inner cell mass (ICM), is able
to contribute to all cells of the three germ layers and is there-
fore referred to as being pluripotent. The other group of
cells, called the trophectoderm (TE), forms an epithelium
surrounding the blastocoel and the ICM and is important
for implantation within the uterus and contributes to the
non-maternal part of the placenta. In the ICM further dif-
ferentiation occurs by the formation of the epiblast, that
will form the foetus, and the formation of extra-embryonic
primitive endoderm (PE) contributing to the yolk sac.
Studies with mouse embryos have advanced our under-
standing of how a pluripotent cell population is established
during pre-implantation development [1-4]. During the first
differentiation, the transcription factors CDX2 and OCT4
are key regulators for the formation of respectively TE and
ICM. CDX2 represses the activity of OCT4 in mouse TE [5]
and is virtually absent in ICM cells [6]. OCT4 in turn can
counteract CDX2 activity in the inner cells of the morula.
The second differentiation is indicated by the expression of
either NANOG or GATA6 in ICM cells fated to become the
epiblast or PE respectively [7]. Like for CDX2 and OCT4 in
the morula, NANOG and GATA6 inhibit each other’s tran-
scription [4]. Whether the same genes and signalling path-
ways are also involved in the formation of a pluripotent cell
population in other mammals remains to be established.
Indeed, in contrast to the mouse, OCT4 protein remains
present in the TE of bovine blastocysts even after transcrip-
tion is down-regulated [8] and its expression is not nega-
tively regulated by CDX2 [9]. In mouse embryos it has been
established that GATA6-stimulated fibroblast growth factor
(FGF) signalling via the extracellular signal-regulated pro-
tein kinase (ERK) is responsible for NANOG repression and
thereby the formation of primitive endoderm [2,10-12]. In
bovine and human embryos however, although GATA6
expression is specific for primitive endoderm, inhibition
of ERK signalling had a more moderate (bovine) or no
(human) effect on the numbers of NANOG and GATA6
expressing cells suggesting that in these species other
pathways are involved in the formation of the pluripotent
cell population [13-15]. These findings suggest species-
specific mechanisms active in the specification of ICM,
TE, epiblast and PE lineages and that further insight is
needed into the molecular basis of cell sorting during the
two first differentiation events.
When mouse ICM cells are cultured under defined condi-
tions, their pluripotent character can be maintained [16,17].
However, the establishment of such embryonic stem (ES)cells has only been successful for mice, non-human primates
[18], humans [19] and rats [20]. Although pluripotency refers
to the capacity to give rise to all embryonic and adult cell
types, including the germ line, various states of pluripotency
have been described. These states are referred to as “naïve”
and “primed”, with “primed” beingmore developmentally re-
stricted [21]. In mammals other than primates and rodents,
the correct stages of embryos that contain pluripotent cells
and culture conditions that maintain pluripotency have yet
to be established [22].
In order to identify genes that may be important for
the acquisition and maintenance of pluripotency in bo-
vine embryos a genome-wide gene expression analysis
was performed in morulae, intact blastocysts, TE and ICM.
Analyses of gene expression patterns in pre-implantation
embryos to distinguish between pluripotent cells of the
ICM versus those of the TE have previously made use of
cell lines because of the technical difficulties of separating
ICM from TE [23,24]. Here we have manually dissected in-
dividual ICMs from TE. As the late ICM is composed of
both pluripotent epiblast cells and the PE, the pluripotent
character of the ICM was enhanced by inhibition of the
ERK-pathway resulting in an increased percentage of ICM
cells that express NANOG.
Results
Gene expression profile of pre-implantation embryos
To identify genes involved in bovine pluripotency, gene ex-
pression profiles of morula and blastocyst embryos, ICM
and TE were generated using microarray analysis. Bovine
cumulus oocyte complexes (COCs) were in vitro matured,
fertilized and cultured for 5 or 9 days to obtain morula
and blastocyst stage embryos, respectively (Figure 1A,B).
In addition, ICM and TE were manually dissected from
day 9 blastocysts (Figure 1C,D). From all samples RNA
was isolated and only those with a RNA integrity number
(RIN) ≥8.0 were used for further analysis. To compensate
for biological and technical errors, two biological replicates
of each sample were labelled with either Cy3 or Cy5 and
hybridized on the arrays with a common reference pool
consisting of blastocysts so all samples could be compared
(Figure 1E).
Samples were hybridized on a microarray slide con-
taining almost 44,000 probes per array coding for ~
14,000 gene transcripts indicating that for a subset of
genes more than one probe was present. If the position
of the probe is nearer to the 3’ end of the correspond-
ing gene, signal intensity is expected to be higher [25]
and chance of incorrect signal by variations in RNA in-
tegrity is smaller [26]. Therefore, the expression of the
probes corresponding to the most 3’ ends of genes was
used for the analysis [27,28]. Gene expression levels in
morula, blastocyst, ICM and TE were determined and
a hierarchical clustering analysis was performed. The
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Figure 1 Microarray set-up and sample validation. RNA from morula (A, purple), blastocyst (B, green), trophectoderm (C, blue) and inner cell
mass (D, orange) was hybridized on microarrays. A common reference sample composed of blastocysts was hybridized with each sample in duplicate in
balanced dye-swap (E, arrows indicate an array and the used fluorescent label; Cy3: green; Cy5: red). The heat map (F) illustrates pairwise clustering of
microarray sample replicates. Yellow colour represents over-expressed probes and blue colour represents under-expressed probes as indicated by the
colour legend (B = blastocyst; ICM = inner cell mass; M = morula; TE = trophectoderm). Representative pictures of immunofluorescent labelling
of dissected ICM (G) and TE (H) for GATA6 (green) and CDX2 (red); double GATA6-CDX2 nuclei appear yellow. Nuclear staining by DAPI (blue). A 2D
principal component analysis plot (I) with sample position indicating clustering of trophectoderm (blue), blastocyst (green), inner cell mass (orange)
and morula (purple) replicates.
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ula, ICM and TE samples (Figure 1F). This is particu-
larly important for the TE and ICM samples since
these were manually dissected and confirms the repro-
ducibility of the dissection. We used mechanical isola-
tion of ICM from TE using tungsten needles. A
selection of isolated ICMs was stained for CDX2 and
GATA6 to identify the contribution of TE cells to the
pooled microarray samples. The isolated ICMs contained
only ~20% CDX2 positive TE (Figure 1G). Since however
some TE cells remained attached to the ICM, throughout
the manuscript “ICM” refers to the ICM containing few TE
cells. In the TE samples all cells were CDX2 and GATA6
positive (Figure 1H). Blastocyst samples did not pair since
their difference with the reference is minimal indicated by a
near black appearance in the heat map. A principal com-
ponent analysis (PCA) further identified four categor-
ies according to cell type or developmental stage. In a
2D plot, morula samples separate the farthest from theother samples. TE and ICM samples are clearly sepa-
rated from each other with the blastocyst replicates in
between (Figure 1I).
To further confirm the specificity of the samples, ex-
pression levels of genes that are known to be differen-
tially expressed in bovine embryos were compared. Of
the selected genes HMGB1, SOX2 and POU5F1 (coding
for OCT4 protein) are known to be expressed at rela-
tively high levels in bovine morula embryos [29-31],
CDX2 and KRT18 have the highest expression levels in
TE [30,32] while FN1 and NANOG are abundantly
expressed in the ICM [30]. The relative expression
levels of the selected genes as determined by micro-
array analysis in morula, blastocyst, ICM and TE were
as expected, with highest levels of HMGB1 and SOX2
expression in morulae, POU5F1 expression predomin-
antly in morulae and ICM, highest FN1 and NANOG
expression in the ICM and CDX2 and KRT18 expression at
highest levels in TE (Figure 2A). These selected genes and
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Figure 2 Relative gene expression. Microarray data were analysed for selected genes known for their expression in morula (purple), blastocyst
(green), ICM (orange) and TE (blue) (A). The same genes were analysed by qRT-PCR in 4–6 samples per embryo stage or cell type revealing the
same pattern (B). Normalization was performed with the reference genes encoding RPL15, SDHA and YWHAZ. Y-axis depicts relative mean
expression to sample with highest expression set at 1 per gene. Bars with different letters are significantly different (p < 0.05) and error bars
indicate standard deviation.
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analysed for their expression levels by qRT-PCR, revealing
a similar expression profile validating sample identity and
demonstrating that the microarray data accurately reflect
relative expression levels (Figure 2B).
Genes differentially expressed between morulae and
blastocysts
Most differences in gene expression were found be-
tween morulae and blastocysts. When gene expression
in morulae was compared with that in blastocysts using
a >2-fold difference with p-value <0.05 as cut-off, 3,774
genes were differentially expressed. In the blastocyst, 1,960
genes were up-regulated, up to 107-fold, while 1,814 genes
were expressed at higher levels in morulae (Figure 3A and
Additional file 2: Table S1). The 25 most differentially
expressed genes were expressed with at least a 30-fold dif-
ference of which only 1 gene (ETNPPL) was expressed at
higher levels in the morula (Table 1).
To identify properties of the differentially expressed genes
a Parametric Analysis of Gene Set Enrichment (PAGE) was
performed using AgriGO [33] and a list of the five most-
enriched gene ontology (GO) terms per categorie was gener-
ated (Table 2). A large group of differentially expressed geneswas involved in the lipid metabolic process (GO:0006629) in
the blastocyst. A much smaller group of genes that function
in pepsin A activity (GO:0004194) was over-represented in
blastocysts and indeed, a large group of genes up-
regulated in the blastocyst located to the plasma mem-
brane (GO:0005886). Compared to the blastocyst, in
the morula more genes were involved in the nucleobase-
containing compound metabolic process (GO:0006139) and
more specifically in RNA processing (GO:0006396). Morula
up-regulated genes were found in the enriched molecular
function GO terms nucleic acid binding (GO:0003676) and
transcription regulator activity (GO:0030528).
Genes differentially expressed between ICM and TE
When gene expression in the ICM was compared with that
of the TE, 497 genes were differentially expressed. Here, the
majority (406) of the differentially expressed genes were
expressed at higher levels in the ICM. Of all genes, the dif-
ference in expression levels of NANOG was the largest (13-
fold up-regulated in the ICM, Table 3 and Additional file 2:
Table S2). SOX2 and POU5F1 that together with NANOG
form the core transcriptional regulatory circuitry in pluri-
potent cells were also over-expressed in the ICM compared
with TE (Figure 3B).
Figure 3 Relative gene expression in blastocyst versus morula
and inner cell mass versus trophectoderm samples. All probes
representing genes (grey) were plotted for their expression levels.
Black lines represent the 2-fold cut off. Axes are Log10 transformed
and depict the normalized expression signal in the indicated sample.
Genes analysed in qRT-PCR are indicated. (A) Genes with significant
(p ≤ 0.05) higher expression levels in blastocyst or morula are
indicated with green or purple dots, respectively. (B) Genes with
significant (p≤ 0.05) higher expression levels in inner cell mass or
trophectoderm are indicated with orange or blue dots, respectively.
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and POU5F1-target genes that encode transcription
factors and chromatin modulators has been established
[34]. From the list of positively regulated genes in hu-
man ES cells, apart from the core network only expres-
sion of STAT3 and ZIC3 was significantly up-regulated
in bovine ICM versus TE (Additional file 2: Table S2).
Again, we performed a parametric analysis of gene set
enrichment with the genes differentially expressed be-
tween ICM and TE in AgriGO [33]. With a false dis-
covery rate (FDR) ≤0.1, enzyme linked receptor protein
signaling pathway (GO:0007167) and peptidyl-tyrosine
phosphorylation (GO:0018108) terms were enriched for
the ICM whereas for the TE, genes were enriched in
the sterol biosynthetic process (GO:0016126) (Table 4).
Only genes up-regulated in respect to the TE were used for
a singular enrichment analysis (SEA) in order to identify
characteristics specific for the cells of the ICM (Additionalfile 2: Table S3). In particular, terms containing genes in-
volved in RNA splicing (GO:0008380) and regulation of
gene expression (GO:0010468) were enriched even to a
more specific level of enriched child terms like nuclear
mRNA splicing (GO:0000398) and chromatin silencing
(GO:0006342), respectively (Figure 4, Additional file 2:
Table S3 and Additional file 3: Figure S2).
Genes differentially expressed between MAPK-inhibited
and control ICMs
It has been described that culture of ICM cells in the
presence of an FGFR inhibitor, a MAPK inhibitor and an
inhibitor of GSK3β, the so-called 3i culture system, leads
to stable ES cell lines from non-permissive mouse strains
[10,35] and rat embryos [20]. Culture of mouse embryos
in the presence of a MAPK inhibitor resulted in all cells
of the ICM expressing Nanog while the expression of
Gata6 was down-regulated [11]. Similarly, when bovine
embryos were cultured in the presence of the MAPK in-
hibitor PD0325901, a larger percentage, although not all,
of the ICM cells expressed NANOG [13]. Therefore, in
order to identify NANOG target genes and genes that
may be important for pluripotency, ICMs were isolated
from bovine embryos cultured in the presence of the
MAPK inhibitor PD0325901. Gene expression in these
ICMs was compared with that from control ICMs using
microarray analysis. In total 94 genes were differentially
regulated between control (DMSO) and MAPK-inhibited
ICMs, ≥2-fold difference with p-value ≤ 0.05 as cut-off,
with the expression of 44 genes up-regulated and the ex-
pression of 50 genes down-regulated (Additional file 2:
Table S4). As expected, NANOG expression was up-
regulated in the MAPK-inhibited ICM as detected by
microarray analysis (Figure 5A,B). Expression differences
between control ICM and ICM from embryos exposed
to the MAPK inhibitor detected by qRT-PCR verified
the microarray data (Figure 5B,C and Additional file 4:
Figure S3). Furthermore, immunostaining showed an in-
crease in the percentage of NANOG expressing cells in
the ICM after MAPK inhibition (Additional file 5: Figure
S4) as we had previously established [13]. To our sur-
prise several interferon coding genes were dramatically
down-regulated after MAPK inhibition such as IFNW1
and IFNT (Figure 5A). Gene expression analysis by qRT-
PCR confirmed the microarray results and further showed
a decreased IFNT expression in TE and to a greater extend
in ICM upon MAPK inhibition (Figure 5D).
Genes up-regulated in the PD-treated or in the control
ICMs were enriched in 189 of the same GO terms after a
singular enrichment analysis containing at least two
genes and a FDR ≤0.1 (Additional file 2: Table S5 and
Figure 5E). When the relative gene expression was taken
into account only 6 GO terms were found to be enriched
with a FDR < 0.1, of which 4 were under-represented in
Table 1 List of the most differentially expressed genes between blastocyst and morula
Rank Entrez Gene name Gene discription AgriGO ID FC
1 PLS1 Plastin-1 ENSBTAP00000053019 107.2
2 PAGE4 G antigen family C member 1 ENSBTAP00000047904 103.9
3 PGHS-2 prostaglandin-endoperoxide synthase 2 (prostaglandin
G/H synthase and cyclooxygenase) (PTGS2), mRNA.
ENSBTAP00000018774 94.1
4 ANXA3 annexin A3 ENSBTAP00000042843 70.5
5 ALDH1A3 aldehyde dehydrogenase 1 family, member A3 ENSBTAP00000012030 64.9
6 SEPP1 selenoprotein P, plasma, 1 (SEPP1), mRNA NP_776884 57.8
7 GCA grancalcin, EF-hand calcium binding protein ENSBTAP00000024550 54.1
8 MYOF myoferlin ENSBTAP00000038769 52.0
9 KRT8 keratin, type II cytoskeletal 8 ENSBTAP00000001108 51.9
10 KRT18 KRT18 proteinUncharacterized protein ENSBTAP00000001988 49.2
11 SLC23A1 solute carrier family 23 (ascorbic acid transporter), member 1 ENSBTAP00000010823 48.7
12 ZFP37 Uncharacterized protein ENSBTAP00000024598 45.6
13 PRSS22 Uncharacterized protein ENSBTAP00000021967 43.2
14 AGRN agrin ENSBTAP00000017563 39.4
15 ETNPPL Bos taurus alanine-glyoxylate aminotransferase 2-like 1 (AGXT2L1), mRNA. ENSBTAP00000013587 −38.8
16 CYP51A1 Lanosterol 14-alpha demethylase ENSBTAP00000002582 36.3
17 LDLR low-density lipoprotein receptor ENSBTAP00000016342 34.4
18 CNN2 Calponin-2 ENSBTAP00000027670 33.8
19 LOC787705 Uncharacterized protein 33.7
20 HMOX1 Heme oxygenase 1 ENSBTAP00000020701 33.2
21 PLAU Urokinase-type plasminogen activatorUrokinase-type plasminogen
activator long chain AUrokinase-type plasminogen activator short
chain AUrokinase-type plasminogen activator chain B
ENSBTAP00000007806 32.9
22 PQLC3 PQ-loop repeat-containing protein 3 ENSBTAP00000027051 31.6
23 PDZK1 Na(+)/H(+) exchange regulatory cofactor NHE-RF3 ENSBTAP00000007638 31.0
24 LOC523509 Uncharacterized protein ENSBTAP00000050990 30.9
25 TMEM20 Bos taurus solute carrier family 35, member G1 (SLC35G1), mRNA. ENSBTAP00000045606 30.0
The 25 most differentially expressed genes (≥30-fold; p ≤ 0.05) between blastocyst and morula are listed. FC = fold-change and positive values indicate higher
expression in blastocyst and negative values have higher expression in morula.
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describing term was receptor binding (GO:0005102) and
this term was under-represented in the PD group.
Cross-comparisons
The 497 genes differentially expressed in the ICM versus
TE and the 95 differentially expressed genes in the
MAPK inhibited versus control ICMs were compared
revealing that 42 genes were shared (Table 6). Of these
genes 15 were both up-regulated in ICM and after MAPK
inhibition while 27 were contra-regulated (Figure 6A).
Only PRPH was expressed at lower levels in ICM than
in TE and 26 genes were down-regulated after MAPK
inhibition and the expression of 16 genes was further
up-regulated (Table 6). Although it has been described
that NANOG activates POU5F1 and SOX2 transcrip-
tion, expression of these genes was not significantlyaltered after up-regulation of NANOG expression by
MAPK inhibition.
The expression of GATA6 was significantly down-
regulated in the ICM after MAPK inhibition, although the
difference was less than 2-fold and was not significant in
the qRT-PCR analysis. The expression of 26 other ICM-
specific genes was significantly down-regulated upon
MAPK inhibition suggesting that these genes are involved
in primitive endoderm formation (Figure 5 and Table 6).
Expression of a number of the genes was also analysed by
qRT-PCR showing a similar pattern and validating the
microarray data (Figure 5 and Additional file 4: Figure S3).
Indeed mouse follistatin, coded by Fst, has been impli-
cated as a marker for primitive endoderm derivatives [36].
Other genes down-regulated in the MAPK inhibited bo-
vine ICMs themselves code for negative regulators of
MAPK activity such as DUSP4 and SPRY4.
Table 2 AgriGO parametric analysis of gene set enrichment (PAGE) analysis (blastocyst versus morula)
GO_acc Ontology Description Genes # p-value FDR
GO:0006629 P lipid metabolic process 311 0 0
GO:0016070 P RNA metabolic process 840 2.70E-29 2.70E-26
GO:0006396 P RNA processing 242 1.00E-28 7.00E-26
GO:0010467 P gene expression 1068 6.50E-22 3.20E-19
GO:0006139 P nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
1169 4.20E-20 1.70E-17
GO:0003676 F nucleic acid binding 929 5.70E-35 2.40E-32
GO:0003723 F RNA binding 252 1.00E-20 2.20E-18
GO:0003677 F DNA binding 623 7.00E-19 1.00E-16
GO:0030528 F transcription regulator activity 445 4.40E-11 4.70E-09
GO:0004194 F pepsin A activity 14 1.40E-10 1.20E-08
GO:0016020 C membrane 1629 0 0
GO:0005886 C plasma membrane 907 0 0
GO:0044425 C membrane part 1280 0 0
GO:0044421 C extracellular region part 564 0 0
GO:0016021 C integral to membrane 1012 0 0
Genes differentially expressed between blastocyst and morula were assessed for their properties described by gene ontology (GO) terms in respect to their
relative expression. The five most significantly enriched GO-terms (according to p-value) are listed for each GO domain. P = Biological Process, F = Molecular
Function and C = Cellular Component. Bold descriptions indicate enrichment for blastocyst. Regular descriptions indicate enrichment for morula. FDR = False
Discovery Rate (Hochberg).
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by gene ontology analysis. A PAGE analysis in AgriGO re-
vealed 59 enriched GO-terms of which none had a FDR <
0.1. When the SEA was performed using either ICM up-
regulated, PD up-regulated or PD down-regulated genes
(Additional file 2: Table S6), a Venn diagram with the
enriched terms (FDR < 0.1) revealed 34 enriched GO-
terms shared between the up-regulated gene compari-
sons (Figure 6B, Additional file 2: Table S6).
Discussion
During bovine pre-implantation development several cell
types display a pluripotent character. The failure in gen-
erating true pluripotent ES cell lines from Bos taurus
embryos however indicates that, compared with murine
and human embryos, other genes are involved in main-
tenance of pluripotency, that the correct embryonic
stage with pluripotent cells has not been used, or that
the culture conditions employed did not sufficiently in-
hibit differentiation. Interestingly, induced pluripotent
stem (iPS) cells generated from bovine cells also behave
differently than mouse iPS cells. Similar to porcine iPS
cells, the introduced transgenes are not silenced in the
currently used culture conditions but remain expressed
in these cells suggesting that other factors are needed
for maintenance of pluripotency [37]. We performed a
microarray analysis comparing morula, blastocyst, ICM
and TE gene expression profiles to identify genes possibly
involved in pluripotency. Further enrichment of thepluripotent character of the ICM was achieved by inhibit-
ing the MAPK pathway through exposure to the MEK
inhibitor PD0325901 during in vitro culture thereby
increasing the percentage of NANOG expressing cells
in the ICM/epiblast [13,14].
To obtain samples for the microarray analysis embryos
were cultured up to the morula stage or blastocyst stage.
Blastocysts were dissected manually to separate ICM
and TE. The advantage of this technique is that ICM
and TE are isolated from the same embryo, in contrast
to for example a technique like immunosurgery. Manually
dissecting blastocysts is challenging however and it is un-
avoidable that few TE cells remain attached to the ICM.
We therefore verified that the separation of the two cell
types was successful. For separation of ICM from TE,
Nagatomo et al. have used either a micromanipulator or
mild trypsin treatment to separate ICM [38]. ICMs isolated
using the micromanipulator still contained 43.3% TE cells
[38]. In our hands the percentage of TE cells remaining in
the ICM isolates was ~20% as determined by CDX2 ex-
pression, indicating a low contribution of TE cells to the
ICM transcriptome. The disadvantage of mild trypsin treat-
ment to isolate ‘pure’ ICM cells, is that TE and ICM can-
not be compared from the same embryo and that the
trypsin treatment by itself may cause a difference in gene
expression. The observation that duplicate samples paired
together and that TE and ICM clustered apart from each
other together with the expected expression patterns of
known TE- and ICM-specific genes in the microarray as
Table 3 List of the most differentially expressed genes between inner cell mass and trophectoderm
Rank Entrez gene name Gene description AgriGO ID FC
1 NANOG Homeobox protein NANOG ENSBTAP00000027863 13.2
2 UPP1 uridine phosphorylase 1 ENSBTAP00000011088 8.9
3 SOX2 SRY (sex determining region Y)-box 2 ENSBTAP00000015411 8.6
4 CAV1 Caveolin-1 ENSBTAP00000023751 7.8
5 AK3L1 Adenylate kinase isoenzyme 4, mitochondrial Q0VCP1 7.5
6 LOC616039 pancreatic trypsin inhibitor-like XP_873093 7.4
7 OTX2 agilent:“Bos taurus orthodenticle homeobox 2 (OTX2), mRNA ENSBTAP00000019616 7.2
8 GPC4 agilent:“Bos taurus glypican 4 (GPC4), mRNA ENSBTAP00000027510 7.1
9 HAS2 hyaluronan synthase 2 ENSBTAP00000026503 7.1
10 SLC4A7 solute carrier family 4, sodium bicarbonate cotransporter, member 7 AAI42306.1 7.1
11 HNF4A agilent:“Bos taurus hepatocyte nuclear factor 4, alpha (HNF4A), mRNA ENSBTAP00000016078 7.0
12 CLIC6 CLIC6 chloride intracellular channel 6 ENSBTAP00000002299 6.9
13 LGALS4 galectin-4 ENSBTAP00000021701 6.8
14 ID1 DNA-binding protein inhibitor ID-1 ENSBTAP00000021521 6.7
15 FLRT3 fibronectin leucine rich transmembrane protein 3 ENSBTAP00000004298 6.6
16 PDGFRA agilent:“Bos taurus platelet-derived growth factor receptor, alpha
polypeptide (PDGFRA), mRNA
ENSBTAP00000009441 6.6
17 NID1 nidogen 1 ENSBTAP00000009531 6.5
18 KIT Mast/stem cell growth factor receptor ENSBTAP00000003498 6.5
19 GRP agilent:“Bos taurus gastrin-releasing peptide GRP mRNA, complete cds. ENSBTAP00000006297 6.5
20 LOC100139916 LOC100139916 interleukin 32-like 6.5
21 TKTL1 Transketolase-like protein 1 ENSBTAP00000036249 6.4
22 A2M Alpha-2-macroglobulin ENSBTAP00000006167 6.4
23 PDYN proenkephalin-B preproprotein AAI51344.1 6.1
24 ACTG2 actin, gamma 2, smooth muscle, enteric ENSBTAP00000036954 6.0
25 MME membrane metallo-endopeptidase ENSBTAP00000002681 6.0
The 25 most differentially expressed genes (>6 fold; p≤ 0.05) between inner cell mass and trophectoderm are listed according to their relative expression. FC = Fold change
and positive values indicate higher expression in inner cell mass.
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was specific and reproducible.
Several genes were represented on the array by multiple
probes and in those cases we only used the expression data
of the most 3’-located probe. Unfortunately, the Bos taurus
genome is not completely annotated [39] and indeed ap-
proximately 5% of the probes representing genes differen-
tially expressed between blastocyst and morula could not
be identified. The other comparisons could be made with
all probes linked to a known differentially expressed gene.
For the Gene Ontology analysis genes need to be associated
with a GO-term. Not all genes are associated with a GO-
term and therefore 3.7% – 5.3% of the genes could not be
analysed in the AgriGO gene ontology analysis.
In vitro derived embryos were used as this enabled us
to generate the numbers needed for RNA extraction.
Particularly for the ICM and TE samples large numbers
of embryos were needed to obtain sufficient amounts of
RNA for hybridization (Additional file 2: Table S7).Although a significant difference in gene expression be-
tween in vitro and in vivo derived embryos has been dem-
onstrated [40] the birth of healthy animals from in vitro
derived embryos indicates that the pathways for pluripo-
tency are functional in these embryos. When gene expres-
sion was compared between different stages of in vivo
derived bovine embryos most genes were found to be
differentially expressed between early development (oo-
cyte-4 cell stage) and later stages (8-cell stage-
blastocyst) [40]. Most likely these differences in gene ex-
pression are caused by embryonic genome activation
around the 8-cell stage [40-42]. A larger number of genes
(~1800) was expressed in in vivo derived oocytes com-
pared with in vitro matured oocytes [40], indicating
that in our study with in vitro derived embryos import-
ant genes may not have been detected. However, since
in vitro derived embryos are commonly used for em-
bryo transfer and give rise to healthy animals, it can be
expected that genes important for pluripotency are
Table 4 AgriGO parametric analysis of gene set enrichment (PAGE) analysis (inner cell mass versus trophectoderm)
GO_acc Ontology Description Genes # p-value FDR
GO:0016126 P sterol biosynthetic process 12 1.40E-11 9.10E-09
GO:0016125 P sterol metabolic process 20 2.00E-09 6.50E-07
GO:0008202 P steroid metabolic process 28 1.00E-07 1.70E-05
GO:0008203 P cholesterol metabolic process 18 8.90E-08 1.70E-05
GO:0006694 P steroid biosynthetic process 20 2.00E-07 2.60E-05
GO:0006629 P lipid metabolic process 62 6.40E-07 6.10E-05
GO:0008610 P lipid biosynthetic process 34 6.40E-07 6.10E-05
GO:0006720 P isoprenoid metabolic process 13 2.10E-05 1.70E-03
GO:0006066 P alcohol metabolic process 54 1.50E-04 1.10E-02
GO:0044255 P cellular lipid metabolic process 39 2.20E-04 1.40E-02
GO:0010038 P response to metal ion 14 3.70E-04 2.20E-02
GO:0006721 P terpenoid metabolic process 11 5.20E-04 2.90E-02
GO:0023034 P intracellular signaling pathway 65 1.70E-03 8.70E-02
GO:0018212 P peptidyl-tyrosine modification 12 2.30E-03 9.40E-02
GO:0018108 P peptidyl-tyrosine phosphorylation 12 2.30E-03 9.40E-02
GO:0007167 P enzyme linked receptor protein signaling pathway 39 2.00E-03 9.40E-02
GO:0031090 C organelle membrane 70 1.90E-04 7.40E-03
GO:0005773 C vacuole 18 1.40E-04 7.40E-03
GO:0042175 C nuclear envelope-endoplasmic reticulum network 23 1.40E-04 7.40E-03
GO:0005789 C endoplasmic reticulum membrane 22 4.70E-04 1.00E-02
GO:0005764 C lysosome 17 5.10E-04 1.00E-02
GO:0000323 C lytic vacuole 17 5.10E-04 1.00E-02
GO:0005768 C endosome 23 1.40E-03 2.20E-02
GO:0012505 C endomembrane system 62 1.50E-03 2.20E-02
GO:0044432 C endoplasmic reticulum part 25 2.30E-03 3.00E-02
All genes differentially expressed between ICM and TE were assessed for their properties described by gene ontology (GO) terms in respect to their relative
expression. This reveals 25 enriched GO-terms with a FDR ≤ 0.1 in the GO domains Biological Process (P) and Cellular Component (C). Ranked according to z-score.
Bold descriptions indicate enrichment for inner cell mass. Regular descriptions indicate enrichment for trophectoderm. FDR = False Discovery Rate (Hochberg).
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tency are functional in in vitro derived embryos.
We started our analysis by comparing gene expression
in blastocysts with that in morulae. This indicated that
most differentially expressed genes are expressed at
higher levels in the blastocyst but a GO-analysis revealed
that most genes expressed at higher levels in morulae
are involved in gene transcription. This might be a result
of the embryonic genome activation initiated during the
8-16 cell stage in cattle embryos preceding the morula
stage [40-42]. Next we tried to identify genes involved in
pluripotency by comparing gene expressions in ICM and
TE. Mouse and human ES cell pluripotency is regulated
by NANOG, SOX2 and OCT4, and these factors en-
hance each other’s transcription [43-45]. Indeed, their
gene expression levels were found higher in the bovine
ICM samples compared with TE. Remarkably, in the
comparison of the ICM with the TE, expression of genes
in the GO-category RNA splicing was specifically up-regulated in the ICM. This indicates a higher transcrip-
tional activity in ICM cells than in TE cells. This is fur-
ther reflected in the >400 genes up-regulated in ICM
compared with TE. Using deep sequencing, Ozawa et al.
examined genes differentially expressed between ICM
and TE of day 8 in vitro derived embryos [32]. All of 8
ICM-characteristic genes that Ozawa et al. found were
also up-regulated in our study, except for ZC3HAV1
and Il6R. Expression of Il6R was indeed significantly up-
regulated in the ICM but the difference was below the
cut-off used (2-fold). These results confirm the specifi-
city and reliability of the ICM isolation and microarray
analysis. Compared with our results Ozawa et al. found
more genes (870 versus 497 in our study) to be differen-
tially expressed between ICM and TE, most likely be-
cause of the less stringent cut-off value used (1.5 versus
2.0 fold difference in our study) [32].
By enhancing the overall NANOG expression in the
ICM we had anticipated that SOX2 and POU5F1 expression
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Figure 4 Biological processes in inner cell mass (partial). All genes expressed at higher levels in inner cell mass compared with trophectoderm were
assessed for their enrichment (GO term analysis in AgriGO) in biological processes (GO:0008150). The hierarchical tree graph contains a highly enriched
group of processes ending in chromatin silencing (GO:0006342) and nuclear mRNA splicing, via spliceosome (GO:0000398).
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embryos cultured in the presence of a MAPK inhibitor, gene
expression levels of NANOG were up-regulated while those
of POU5F1 and SOX2 remained relatively unchanged. These
results suggest that in bovine cells NANOG by itself is not
sufficient inmaintaining the core pluripotency network.
An unexpected result was the expression of several
interferon-coding genes in the ICM. Various reports have
described exclusive IFNT expression in trophectoderm or
TE derived cell lines [46-48]. We detected IFNT expression
in the isolated ICMs at similar levels as in TE however andthe expression in the ICM was down-regulated upon
MAPK inhibition even to a greater extent than in TE. In
ungulates, interferon tau (coded by IFNT) expression by
TE is important for maternal pregnancy recognition [49].
In bovine day 7 blastocysts interferon tau has been detected
at varying intensity in the TE and was concentrated at the
border of the ICM and TE [48]. By dissecting the ICM, part
if not all of the interferon tau-positive adjacent cells have
been included in the ICM samples accounting for the ob-
served IFNT expression in the ICM samples. Together with
CDX2 predominantly expressed in TE cells and capable of
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Figure 5 Expression in and GO-analysis of MAPK-inhibited and control inner cell mass. All probes representing genes (grey) were plotted for
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indicated sample. Genes discussed in text (and analysed by qRT-PCR) are indicated. Genes with significant (p ≤ 0.05) higher expression levels in
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the greater expression reduction found in ICM (20-fold)
than in TE (4-fold). Nevertheless, our results and the previ-
ously reported location of interferon tau expression [48] donot exclude IFNT expression in the ICM even though its
function in the ICM is unknown.
After exposure to PD0325901 expression of NANOG
in the ICM was enhanced as compared to control ICMs.
Table 5 AgriGO parametric analysis of gene set enrichment (PAGE) analysis (MAPK inhibited versus control)
GO_acc Ontology Description Genes # p-value FDR
GO:0005102 F receptor binding 12 0.0016 0.027
GO:0005615 C extracellular space 26 7.60E-05 0.003
GO:0044421 C extracellular region part 28 0.00019 0.0036
GO:0005576 C extracellular region 34 0.0033 0.043
GO:0043232 C intracellular non-membrane-bounded organelle 18 0.0093 0.073
GO:0043228 C non-membrane-bounded organelle 18 0.0093 0.073
All genes differentially expressed between MAPK-inhibited and control ICMs were assessed for their properties described by gene ontology (GO) terms in
respect to their relative expression. This revealed 6 enriched GO-terms with a FDR ≤ 0.1 in the GO domains Molecular Function (F) and Cellular Component
(C). Bold descriptions indicate enrichment in MAPK inhibited ICM. Regular descriptions indicate enrichment in control ICM.
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containing NANOG binding sites [51]. Of the 42 genes
identified to be differentially expressed in bovine ICMs and
after MAPK inhibition, only five were homologous to mur-
ine genes containing NANOG binding sites. Of those
genes only expression of NANOG was up-regulated after
MAPK inhibition. Of the remaining four, CD8B, DUSP4,
JAM2 and SPRY4, the expression was enhanced in the
ICM but their expression was down-regulated after MAPK
inhibition. The role of the glycoprotein CD8B in early em-
bryonic development, and more specifically in the ICM, is
unclear. Its expression can be regulated however by MAPK
signalling [52,53] possibly accounting for the observed
down-regulation after PD0325901 treatment. DUSP4 is
suggested to function in the negative feedback control of
MAPK signalling specifically dephosphorylating ERK1/2
[54,55]. Also SPRY4 is known for its involvement in the
MAPK pathway by interacting with GRB2 and GAP1 and
as such inhibiting RAS activation [56] and antagonizing
FGF activity [57]. Therefore, the down regulation of
DUSP4 and SPRY4 expression by MAPK inhibition is most
likely a direct result of the MAPK inhibition rather than
result from the up-regulation of NANOG expression.
JAM2 is expressed in both embryonic and adult stem cell
lines [58] and its expression is enhanced in undifferentiated
mouse ES cells compared to early stages of differentiation.
Since mouse ES cells that genetically lack Jam2 maintain
pluripotency however, the function of JAM2 in stem cells
remains unknown [59]. In mouse Sertoli cells inhibition of
ERK activity did not affect Jam2 transcription [60], suggest-
ing that the observed reduced JAM2 expression resulted
from increased NANOG levels. Interestingly, JAM2 expres-
sion was also down-regulated after OCT4 had been ex-
ogenously introduced into human cells, suggesting that
low levels of JAM2 induce or indicate differentiation [61].
In our bovine ICMs POU5F1 expression was however not
significantly up-regulated after enhanced NANOG expres-
sion. Surprisingly, no other genes that had been identified
as overlapping NANOG putative targets in mouse and hu-
man ES cells [51] appeared to be up- or down-regulated in
bovine ICMs with enhanced NANOG expression.Apart from the core pluripotency markers NANOG,
SOX2 and OCT4, other transcription factors are re-
ported to be involved in mouse or human pluripotency.
Of all transcription factors differentially expressed be-
tween ICM and TE, OTX2 ranked third and was 7.2-fold
higher expressed in ICM. In mouse ES cells OTX2 was
reported to be required for the transition to a stable epi-
blast stem cell condition [62]. Recently, it was shown
that OTX2 is one of the earliest transcription factors to
be activated during exit from a naïve ground state in
mES cells [63]. Although the MAPK pathway is import-
ant in cell differentiation [35] and therefore might influ-
ence OTX2 expression we did not detect a difference in
OTX2 expression in the PD treated bovine ICMs. To-
gether, these findings suggest that the ICMs under inves-
tigation were already in a “primed” state.
Transcription factors involved in the LIF or BMP pathway
were also amongst the genes with up-regulated expression
levels in the ICM. Although BMP4 was not differentially
expressed, STAT3 (2.5-fold), ID3 (2.7-fold) and ID1 (6.7-fold)
were expressed at higher levels in ICM than in TE. STAT3 is
capable of suppressing mesoderm and endoderm commit-
ment whereas ID genes suppress neuroectoderm commit-
ment inmES cells. Fibronectin, with expression levels almost
4-fold higher in ICM, can induce Id expression and also
NANOG is capable of activating STAT3 and inducing ID
genes [64]. Up-regulated NANOG expression did however
not induce STAT3 or ID expression in MAPK inhibited
ICMs. Although the level of expression might not be high
enough, the increased expression of STAT3, ID1 and ID3
suggests that, although in a primed state, differentiation is
not initiated yet in the bovine day 9 ICMs.
The transcription factor PRDM14 is implicated to act as a
safeguard for maintaining pluripotency [65] and is uniquely
expressed in mouse compacted morula, ICM, the early epi-
blast, primordial germ cells and ES cells [66-68]. Indeed, the
expression of PRDM14 was found to be up-regulated in bo-
vine morulae compared to blastocysts (2.4-fold; p = 0.00097)
and ICM versus TE (2.5-fold; p = 0.0015). It has been re-
ported that in mouse ES cells PRDM14 attenuates FGF-
induced differentiation [68]. We did however not observe a
Table 6 List of genes differentially expressed in ICM
versus TE and PD treated versus control ICMs
Gene name FC (ICMvsTE) FC (PDvsControl)
ADH6 3.336 −2.993
AHCYL2 5.379 2.068
C8A 2.558 2.009
CD8B 3.392 −2.010
CKB 3.660 2.062
CTSC 3.064 −2.517
CYP1A1 4.041 −2.563
DHRS7 3.717 2.170
DUSP4 3.685 −6.320
EMILIN2 5.463 2.697
FBLN1 2.215 −2.160
FST 2.468 −3.235
GKN2 2.615 −2.426
HAS2 7.117 −2.237
JAM2 2.205 −2.186
LOC100139049 2.661 2.276
LOC100139916 6.461 −2.002
LOC100140174 3.096 2.880
LOC616039 7.437 −2.203
MAP1B 3.657 2.032
MEIS2 3.638 −2.508
MFAP5 4.520 −2.403
MYL9 2.257 3.305
NANOG 13.215 2.575
NID1 6.536 −2.072
P4HA3 3.279 2.083
PDGFRA 6.583 −2.116
PDYN 6.053 −2.398
PHLDA1 2.679 −2.133
PRPH −2.552 2.124
PRSS12 4.640 2.334
RSPO3 2.572 −2.619
S100B 3.875 3.516
SELP 2.758 2.466
SERPINA5 5.908 −7.057
SERPINH1 2.673 −2.110
SLC1A3 3.230 −2.249
SPRY4 4.314 −2.065
TGM2 3.363 −2.231
TIFA 3.394 −2.569
unknown 2.868 2.076
VIM 4.636 −2.827
Alphabetical ranking of differentially expressed genes (p < 0.05) in inner cell
mass versus trophectoderm (ICMvsTE) and MAPK-inhibited versus control inner
cell masses (PDvsControl). FC = Fold change in respect to ICM or PD.
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Figure 6 Gene expression and processes in the inner cell mass. (A)
Of the 497 genes differentially expressed (≥2-fold; p≤ 0.05) between
ICM and TE (orange) several are up-regulated (bold) or down-regulated
(regular) and 42 of these are also differentially expressed when inner cell
masses treated with the MAPK-inhibitor PD0325901 (PD) are compared
with control inner cell masses (magenta). This latter comparison
retains 95 differentially expressed genes. Of the 42 shared genes 15
are up-regulated in both comparisons and 27 are contra-regulated
(italics and underlined). (B) A gene ontology analysis with 41 ICM
up-regulated genes (orange), 16 PD up-regulated (red) and 26 PD
down-regulated (green) genes indicates several GO-terms of which
34 are enriched in both up-regulated gene analyses.
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inhibited ICMs (1.07 fold difference; p = 0.87), suggesting
that the FGF- or MAPK-signalling pathways do not repress
PRDM14 expression in bovine pluripotent cells. Expression
of the ZIC gene family members ZIC2 and ZIC3 was also
up-regulated in the ICM (4.3-fold and 2.2-fold, re-
spectively). Zic2 and its orthologues are expressed in
frog [69] and zebrafish [70], pregastrulation embryos
and in mouse E0.5 and ICM of E4.5 embryos [71].
Zic3 is implicated to play an important role in main-
taining pluripotency in mouse ES cells [72] and contains
OCT4, NANOG and SOX2 binding sites [34,51]. Indeed,
after increased NANOG expression by MAPK inhibition
ZIC3 expression increases 1.5 fold (p = 0.038) but ZIC2 ex-
pression decreased 2.2-fold (p > 0.05). Other reported genes
Brinkhof et al. BMC Genomics  (2015) 16:277 Page 14 of 18to safeguard pluripotency such as PARP1 and PARP7 [73]
were expressed at higher levels in morula than in blastocyst
(PARP7), did not show a differential expression between
ICM and TE and were not differentially expressed after
MAPK inhibition. All together, these findings indicate
that, despite the increased ZIC3 and NANOG expres-
sion, MAPK inhibition by PD0325901 is insufficient to
maintain a pluripotent state in bovine ICM cells.
Conclusion
We have identified whole genome expression profiles of
different stages of bovine embryos and TE and the pluri-
potent ICM of blastocysts. In addition, the transcrip-
tome of ICMs with enhanced NANOG expression after
inhibition of MAPK activity was established. Unfortu-
nately, these expression profiles did not lead to (new)
pathways or indications how to maintain pluripotency
and possibly generate genuine bovine ES cells. Further-
more, it became apparent that although MAPK inhibition
increased NANOG and ZIC3 expression, this is insufficient
to maintain pluripotency. Comparing transcription factor
expression in the bovine ICMs used in the microarray with
known expressions in mouse pluripotent cells indicates a
“primed” or epiblast state. Therefore, the data presented in
this paper can act as a starting point for further research
on bovine pluripotency.
Methods
Bovine in vitro embryo culture and mechanical separation
Bovine embryo culture was performed at 39°C in a hu-
midified atmosphere with 5% CO2, unless stated other-
wise. Three to eight mm follicles of ovaries, obtained
from a local slaughterhouse, were aspirated to retrieve
COCs. Groups of 35–60 COCs were incubated for
23 hrs in 500 μl M199 (Life Technologies, Bleiswijk, The
Netherlands) supplemented with 0.05 IU/ml recombinant
hFSH (Organon, Oss, The Netherlands) and with 1% (v/v)
penicillin-streptomycin (Life Technologies). Fertilization
was performed as described previously [74] with modifica-
tions as described [75]. In short, matured COCs were
transferred to fertilization medium (Fert-TALP) supple-
mented with heparin at a final concentration of 10 μg/ml
(Sigma-Aldrich, Zwijndrecht, The Netherlands), 20 μM
D-penicillamine (Sigma-Aldrich), 10 μM hypotaurine
(Sigma-Aldrich), and 1 μM epinephrine (Sigma-Aldrich).
Frozen-thawed sperm from a bull with proven fertility
was centrifuged over a Percoll-gradient (GE Healthcare
Europe GmbH, Eindhoven, The Netherlands) and added
to the COCs at a final concentration of 1.0 × 106 sperm-
atozoa/ml. Fertilization day was considered as day 0.
After incubation for 20 hrs the COCs were denuded by
vortexing for 3 min and the cumulus-free oocytes were
placed in synthetic oviduct fluid (SOF) medium. The pre-
sumptive zygotes were incubated at 39°C in a humidifiedatmosphere with 7% O2 and 5% CO2. At day 5 either mor-
ulae were collected or embryos were transferred to fresh
SOF medium, cultured to blastocyst stage embryos and
collected on day 9. Embryos were cultured until day 9 of
development as this resulted in a higher percentage of
hatching and hatched blastocysts [30,76,77], which facili-
tated ICM from TE separation. To ensure good quality
embryos only stage code 7–9 blastocysts with quality
code 1 or 2, according to the IETS manual, were collected
[78,79]. To obtain ICMs containing a higher percentage
of NANOG-expressing cells, SOF medium was supple-
mented with a final concentration of 0.5 μM PD0325901
(Stemgent, Cambridge, MA, USA) at day 5. Embryo cul-
ture for control ICM samples was performed with equal
concentrations of the solvent DMSO.
Blastocysts collected to obtain inner cell mass and
trophectoderm were placed in wash buffer containing
6.67 mg/ml NaCl (Merck, Schiphol-Rijk, The Netherlands),
0.24 mg/ml KCl (Merck), 0.168 mg/ml NaHCO3 (Sigma-
Aldrich), 0.047 mg/ml NaH2PO4 (Merck), 0.217% (v/v) of a
60% sodium lactate solution (Sigma-Aldrich), 2.38 mg/ml
HEPES (Sigma-Aldrich), 0.2% (v/v) phenolred (Sigma-Al-
drich), 0.39 mg/ml CaCl2 · 2H2O (Sigma-Aldrich), 0.10 mg/
ml MgCl2 · 6H2O (Merck), 0.11 mg/ml sodium pyruvate,
100U/ml Penicillin-Streptomycin (Life Technologies) and
6.0 mg/ml bovine serum albumin fraction 5 (MP Biomedi-
cals, Santa Ana, CA, USA), set at an osmolality of 280 os-
mol/kg and adjusted to pH 7.3.
Sharpened tungsten needles were used to manually
separate the trophectoderm from the ICM. This pro-
cedure was performed in wash medium under a stereo
microscope.
RNA isolation
Collected cells and embryos were harvested per tissue
type or treatment and stored in 100 μl extraction buffer
(Life Technologies) at −80°C until RNA isolation. RNA
isolation and on column DNA digestion (Qiagen, Venlo,
The Netherlands) was performed using the PicoPure®
RNA isolation kit (Life Technologies) according to the
manufacturer’s protocol. Total RNA quality and quantity
assessment was performed by micro-electrophoresis on
a Bioanalyzer 2100 using the RNA 6000 Pico LabChip
kit (Agilent Technologies, Amstelveen, The Netherlands)
according to manufacturer’s instructions. RNA was
stored at −80°C until further use.
Microarray gene expression analysis
Selected total RNA samples were compared in a com-
mon reference experiment design using 12 dual channel
microarrays (8 for the stage-/cell-specific microarray and
4 for the ERK-inhibition microarray) with each sample
hybridized against an identical common reference total RNA
sample consisting of a pool of blastocysts total RNA. Within
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treatment, sample versus common reference hybridizations
were performed in balanced dye-swap.
Microarrays used were bovine whole genome gene ex-
pression microarrays V2 (Agilent Technologies) repre-
senting 43,653 Bos taurus 60-mer oligos in a 4x44K
layout.
cDNA synthesis, cRNA double amplification, label-
ling, quantification, quality control and fragmentation
were performed with an automated system (Caliper Life
Sciences NV/SA, Teralfene, Belgium), starting with 10–
20 ng total RNA from each sample, all as previously
described in detail [80,81]. Microarray hybridization
and washing was with an HS4800PRO system with Quad-
Chambers (Tecan, Mechelen, Belgie) using 700 ng, 1-2%
Cy5/Cy3 labelled cRNA per channel as described [80].
Slides were scanned on an Agilent G2565BA scanner at
100% laser power, 30% PMT. After automated data extrac-
tion using Imagene 8.0 (BioDiscovery, Hawthorne, CA,
USA), Loess normalization was performed [82] on mean
spot-intensities. Gene-specific dye bias was corrected by a
within-set estimate [83]. Data were further analysed by
MAANOVA [84], modelling sample, array and dye effects
in a fixed effect analysis. P-values were determined by a
permutation F2-test, in which residuals were shuffled
10000 times globally. Gene probes with p < 0.05 after
false discovery rate determination (FDR by Benjamini-
Hochberg) were considered significantly changed. In
cases of multiple probes per gene, the values from the
most 3′ probe were used [27,28]. To determine differ-
entially expressed genes a fold change cut-off of 2 fold
was used. All microarray gene expression data have
been deposited in NCBI’s Gene Expression Omnibus
[85] and are accessible through GEO Series accession
number GSE63054 [86].
Quantitative reverse transcription-PCR
RNA was converted to cDNA using the iScript™ cDNA
Synthesis Kit (BioRad, Veenendaal, The Netherlands) ac-
cording to manufacturer’s instructions. Primers (Life
Technologies; Additional file 2: Table S8) for specific Bos
taurus mRNA templates [87] were designed using a
Primer3 based platform [88]. Further in silico validation
was performed by predicting PCR product folding struc-
tures using the Mfold web server [89-91]. For quantita-
tive reverse transcription PCR (qRT-PCR) we used iQ™
SYBR® Green supermix on a MyiQ detection system
(Biorad) in a 25 μl reaction volume with a final primer
concentration of 400nM according to manufacturer’s in-
structions. To confirm specificity of primer pairs and es-
tablish melting temperatures (Tm) a temperature gradient
was performed ranging from 57.0°C – 65.3°C using a 4
times dilution series of cDNA from blastocyst samples.
Reactions started with a 5 min enzyme activation cycle at95°C continued with 45 cycles in which the first step
was 20 sec denaturing at 95°C, followed by 30 sec at
Tm (Additional file 2: Table S8) for annealing and the
third step for 30 sec at 72°C for elongation. To generate
a dissociation curve the reaction continued by increas-
ing the temperature from 60°C to 98°C per 0.5°C for
15 sec each step. For expression analysis of the individ-
ual samples the primer specific optimal Tm was chosen
(Additional file 2: Table S8) and the dissociation curve
was generated with 1°C temperature increments per
step until 98°C.
Immunostaining
ICM, TE and blastocyst samples were collected and fixed
in 4% paraformaldehyde (PFA) for 15 min and stored in
1% PFA at 4°C until further use. Samples were perme-
abilized in PBS + 10%FCS + 0.5% Triton X100 (Sigma
Aldrich) for 30 min. Next, a-specific binding was
blocked by incubating the samples in PBS + 10% FCS +
0.1% Triton X100 (PBST) for 1 hour before overnight in-
cubation with primary antibodies rabbit anti-GATA6
(Santa Cruz;sc-9055;1:100), mouse anti-CDX2 (Biogenex;
CDX2-88; 1:200) or mouse anti-NANOG (eBiosciences;
14-5768-82;1:250) at 4°C. Secondary antibody incubation
for 1 hour with appropriate goat anti mouse Alexa647 or
goat anti rabbit Alexa 488 dye (Invitrogen, Venlo, The
Netherlands) and subsequent nuclear staining using
DAPI (Sigma Aldrich) for 5 min preceded Vectashield
(Brunschwig Chemie, Amsterdam, The Netherlands)
mounting in Grace Bio-Labs SecureSeal™ imaging spacer
(Sigma-Aldrich). All incubations were performed at
room temperature unless stated otherwise.
Fluorescent images were obtained using an inverted
semi-automated confocal microscope (SPE-II – DMI4000;
Leica, Son, The Netherlands) and further analysed with Fiji
software [92].
Additional files
Additional file 1: Figure S1. Relative gene expression; additional data.
Microarray expression data (A) were analysed for additional genes by
qRT-PCR (B) in morula (purple), blastocyst (green), ICM (orange) and TE
(blue). Normalization was performed with reference genes RPL15, SDHA
and YWHAZ. Y-axis depicts relative mean expression to sample with highest
expression set at 1 per gene. Bars with different letters are significantly
different (p < 0.05) and error bars indicate standard deviation.
Additional file 2: Table S1. Comparison of relative gene expression
between blastocyst and morula. All genes differentially expressed (≥2-fold;
p≤ 0.05) between blastocyst and morula are ranked according to their relative
expression. Positive numbers indicate enhanced expression in blastocysts and
negative numbers indicate lower expression in blastocysts. Table S2. Relative
expression of genes comparing ICM and TE. All genes differentially expressed
(≥2-fold; p≤ 0.05) between ICM and TE are ranked according to their relative
expression. Positive numbers indicate higher expression in blastocysts and
negative numbers indicate lower expression in blastocysts. Table S3. Singular
enrichment analysis of ICM up-regulated genes. List of all enriched GO-terms.
Table S4. Gene expression MAPK inhibited versus control ICMs. All genes
Brinkhof et al. BMC Genomics  (2015) 16:277 Page 16 of 18differentially expressed (≥2-fold; p≤ 0.05) between MAPK inhibited versus
control ICMs are listed according to their relative expression. Positive numbers
indicate higher expression in MAPK-inhibited ICMs and negative numbers
have higher expression in control ICMs. Table S5. Singular enrichment analysis
of up-regulated genes in the PD treated or in the control ICMs. GO-terms
enriched for genes with up-regulated expression (PD), with down-regulated
expression (DMSO) or in both analyses (PD &DMSO). Table S6. GO-
terms enriched with ICM up-regulated, PD up- or PD down-regulated
genes. Singular enrichment analysis with ICM up-regulated, PD up- or
PD down-regulated genes (minimum of two genes in a GO-term and a
false discovery rate ≤0.1). Table S7. Microarray sample composition.
Numbers of embryos used for RNA extraction and subsequent microarray
study are presented per sample. Note; Blastocyst sample 1 and 2 (B1 and B2)
are identical to Blastocyst pool 1 and 2 (Bp1 and Bp2) respectively. Table S8.
Primers used for qRT-PCR. Gener indicates a reference gene used for
normalization.
Additional file 3: Figure S2. Hierarchical tree graph of GO-terms
enriched with ICM vs. TE up-regulated genes in the biological process
GO-domain. All 406 up-regulated genes in the ICM versus TE comparison
were analysed for their enrichment in biological processes by a singular
enrichment analysis.
Additional file 4: Figure S3. Relative gene expression in control and
MAPK-inhibited inner cell mass; additional data. Microarray expression data
(A) were confirmed by qRT-PCR (B) for 7 additional genes. MAPK-inhibited
ICM (red) results are depicted relative to control ICM (green) expression.
Normalization was performed with the reference genes RPL15, SDHA and
YWHAZ. Error bars indicate standard deviation and significant differences are
indicated by * p < 0.05; ** p < 0.005; *** p < 0.0005.
Additional file 5: Figure S4. Effect of MAPK inhibition.
Immunofluorescent staining for GATA6 (green) and NANOG (red) to
determine protein distribution in control (upper panels) and MAPK-
inhibited (lower panels) embryos. DAPI was used for nuclear staining.
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